Contemporary Monoclonal Antibody Utilization in Glomerular Diseases

Therapeutic monoclonal antibodies (MAbs) have been one of the fastest growing drug classes in the past 2 decades and are indicated in the treatment of cancer, autoimmune disorders, solid organ transplantation, and glomerular diseases. The Food and Drug Administration has approved 100 MAbs between 19...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansour, Iyad, Murugapandian, Sangeetha, Tanriover, Bekir, Thajudeen, Bijin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338194/
https://www.ncbi.nlm.nih.gov/pubmed/37448529
http://dx.doi.org/10.1016/j.mayocpiqo.2023.04.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338194/
https://www.ncbi.nlm.nih.gov/pubmed/37448529
http://dx.doi.org/10.1016/j.mayocpiqo.2023.04.009

Ejemplares similares